Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab.
Cancers (Basel). 2021 Jan 6;13(2):168. doi: 10.3390/cancers13020168.
Cancers (Basel). 2021.
PMID: 33418936
Free PMC article.
Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection Methods.
Schats KA, Van Vré EA, Boeckx C, De Bie M, Schrijvers DM, Neyns B, De Meester I, Kockx MM.
Schats KA, et al.
Arch Pathol Lab Med. 2018 Aug;142(8):982-991. doi: 10.5858/arpa.2017-0159-OA. Epub 2018 Apr 2.
Arch Pathol Lab Med. 2018.
PMID: 29607663
Free article.
Item in Clipboard
Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases.
Jansen YJL, Verset G, Schats K, Van Dam PJ, Seremet T, Kockx M, Van Laethem JB, Neyns B.
Jansen YJL, et al. Among authors: schats k.
ESMO Open. 2019 Mar 5;4(2):e000464. doi: 10.1136/esmoopen-2018-000464. eCollection 2019.
ESMO Open. 2019.
PMID: 30962963
Free PMC article.
Item in Clipboard
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.
Jansen Y, Kruse V, Corthals J, Schats K, van Dam PJ, Seremet T, Heirman C, Brochez L, Kockx M, Thielemans K, Neyns B.
Jansen Y, et al. Among authors: schats k.
Cancer Immunol Immunother. 2020 Dec;69(12):2589-2598. doi: 10.1007/s00262-020-02618-4. Epub 2020 Jun 26.
Cancer Immunol Immunother. 2020.
PMID: 32591862
Free PMC article.
Clinical Trial.
Item in Clipboard
Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.
Seremet T, Koch A, Jansen Y, Schreuer M, Wilgenhof S, Del Marmol V, Liènard D, Thielemans K, Schats K, Kockx M, Van Criekinge W, Coulie PG, De Meyer T, van Baren N, Neyns B.
Seremet T, et al. Among authors: schats k.
J Transl Med. 2016 Aug 2;14(1):232. doi: 10.1186/s12967-016-0990-x.
J Transl Med. 2016.
PMID: 27484791
Free PMC article.
Item in Clipboard
Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system.
Schats KA, Van Vré EA, De Schepper S, Boeckx C, Schrijvers DM, Waelput W, Fransen E, Vanden Bempt I, Neyns B, De Meester I, Kockx MM.
Schats KA, et al.
Histopathology. 2017 Jan;70(2):253-263. doi: 10.1111/his.13056. Epub 2016 Oct 10.
Histopathology. 2017.
PMID: 27496355
Item in Clipboard
Cite
Cite